Andrew Sharabi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) (NCT03050554) | Andrew Sharabi | 2017-10-26 |
Track Andrew Sharabi automatically
Every clearance here is in the API, with alerts when new ones post.